Pierre Fabre Fights Off Rivals For Rights To Atara's Allogeneic T-Cell Therapy

Tab-Cel Granted Accelerated Assessment By EMA For Rare Cancer

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.